Skip to main navigation Skip to search Skip to main content

IMMUNISATION WITH A POLYVALENT PNEUMOCOCCAL VACCINE. Reduction of Adult Respiratory Mortality in a New Guinea Highlands Community

  • I. D. Riley
  • , M. Andrews
  • , R. Howard
  • , P. I. Tarr
  • , M. Pfeiffer
  • , P. Challands
  • , G. Jennison
  • , R. M. Douglas

Research output: Contribution to journalArticlepeer-review

Abstract

A double-blind controlled trial of a 14-valent pneumococcal polysaccharide vaccine was carried out in 11 958 adults at Tari in the Papua New Guinea Highlands. Pneumococcal infection, confirmed by blood-culture and lung aspirate, was less in the vaccinated group by 84%. Mortality from pneumonia was less by 44%.

Original languageEnglish
Pages (from-to)1338-1341
Number of pages4
JournalThe Lancet
Volume309
Issue number8026
DOIs
StatePublished - Jun 25 1977

Fingerprint

Dive into the research topics of 'IMMUNISATION WITH A POLYVALENT PNEUMOCOCCAL VACCINE. Reduction of Adult Respiratory Mortality in a New Guinea Highlands Community'. Together they form a unique fingerprint.

Cite this